Impact of multi-cohort HPV vaccination on cervical cancer in women below 30 years of age: Lessons learned from the Scandinavian countries
- Published on 01/03/2025
- Reading time: 4 min.
Ståle Nygård, 1, Thea Falkenthal, 1, Tina Sture, 1, Elsebeth Lynge, 2, Miriam Elfström, 3, Mari Nygård 1
1 Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway
2 Zealand University Hospital, Nykøbing Falster, Denmark
3 Center of Cervical Cancer Elimination, Department of Clinical Science Intervention & Technology, Karolinska Institutet, Stockholm, Sweden
Corresponding author contact information: Ståle Nygård and Mari Nygård, Department of Research, Cancer Registry of Norway, P.O. Box 5313 Majorstuen, N-0304, Oslo, Norway, Tel.: +47-22451300, E-mail: stale.nygard@kreftregisteret.no
Abstract
In Scandinavia, HPV vaccination programs started in 2007/8; in Sweden and Denmark with HPV vaccination offered to multiple cohorts of young girls, while in Norway offered to a single cohort only. Interestingly, in Sweden and Denmark, cervical cancer incidence in young women decreased markedly from 2017/2018, while in Norway a steady increase was seen until 2020. As the three countries are very similar in other factors important for cervical cancer incidence rates like cervical...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Radiology
Receive our newsletter to stay up to date with the latest news in Radiology
